Patent · US Active

Compositions comprising urolithins and uses thereof for the stimulation of insulin secretion

US11213508B2 · kind B2 · utility

0Cited by

1References

15Claims

0Family size

Assignees

Universite De Montpellier · FR
University de Parma · IT
Ecole Nationale Supérieure de Chimie de Montpellier · FR

Inventors

Gerard Cros · Montpellier, FR
Alan Crozier · Glasgow, GB
Margherita Dall'asta · Parma, IT
Daniele Del Rio · Parma, IT
Richard Magous · Lunel, FR
Catherine Oiry · Pignan, FR

Key dates

Filing date	Jan 24, 2020
Grant date	Jan 4, 2022
Priority date	—
Expiry date	Jan 24, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA23V2002/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a composition comprising urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, for the stimulation of insulin secretion, and to the use of a compound chosen among urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, intended for the stimulation of insulin secretion. The present invention also relates to a composition comprising an effective amount of urolithin B, urolithin C, urolithin D, or a combination thereof, for the treatment or the prevention of diabetes mellitus, and in particular for the treatment or the prevention of type 2 diabetes, and to the use of a compound chosen among urolithin B, urolithin C, urolithin D, and a combination thereof, intended for the treatment or the prevention of diabetes mellitus, and in particular of type 2 diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.